The Utilization of Chinese Herbal Products for Hyperthyroidism in National Health Insurance System (NHIRD) of Taiwan: A Population-Based Study

Table 3

Top five most-used two-formula CHPs and two-single CHPs for the treatment of hyperthyroidism between 2000 and 2013 in Taiwan (total prescriptions, n = 15,860).

Two-formula CHPs	Number; frequency (%)	Number of person-days	Average daily dose (g)	Average duration for prescription (days)
Jia-Wei-Xia-Yao-San/Zhi-Gan-Cao Tang	106; 0.67	4396	4.9/4.1	11
Zhi-Bo-Di-Huang-Wan/Zhen-Ren-Huo-Ming-Yin	69; 0.44	1442	4/4	10.9
Tian-Wang-Bu-Xin-Dan/Jia-Wei-Xia-Yao-San	48; 0.3	3090	4.8/4.9	9.4
Tian-Wang-Bu-Xin-Dan/Kan-Mai-Ta-Tsao-Tang	48; 0.3	1367	4.8/3.8	11.7
Jia-Wei-Xia-Yao-San/San-Zhong-Kui-Jian-Tang	47; 0.3	1737	4.9/4.2	11.2
Two-single CHPs
Xuan-Shen/Xia-Ku-Cao	140; 0.88	4486	1.1/3.1	10.7
Xuan-Shen/Bei-Mu	125; 0.79	2655	1.1/2.2	9
Bei-Mu/Xia-Ku-Cao	114; 0.72	3382	2.2/3.1	11.5
Xuan-Shen/Mu-Li	106; 0.67	2738	1.1/1.2	10
Mu-Li/Xia-Ku-Cao	93; 0.59	2338	1.2/3.1	11.6

CHPs, Chinese herbal products.